A wild weather system pummelled Sydney for a second day on Wednesday (July 2), with the storm forcing the cancellation of dozens of flights, bringing down trees and taking out power to thousands of ...

Watch as technology takes flight! 🚀 This new rocket launch is set to explore the mysteries of heatwaves and their impact on our planet. Buckle up for a scientific journey that could change our ...

Honda's reusable rocket prototype flies during a successful launch and landing test on June 17, 2025. (Image credit: Honda) Honda said it achieved its intended objectives for the launch and ...

Unusual gene duo in wild wheat offers new hope against crop diseases by Erin Matthews, University of Saskatchewan edited by Sadie Harley, reviewed by Robert Egan Editors' notes ...

GEORGETOWN, Guyana (CMC) — The One Health Platform, launched in 2022 to help Guyana better prepare for diseases that can spread from wildlife to humans, was officially handed over to the Guyana ...

Rocket Pharmaceuticals, Inc.’s (NASDAQ:RCKT) prospects have taken a significant hit on the company being forced to halt research on its experimental gene therapy for Danon Disease.

Rocket Pharmaceuticals halted its Danon disease gene therapy trial after a patient death, with the FDA placing the study on clinical hold for review.

CRANBURY, N.J., May 27, 2025--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing an integrated pipeline of genetic therapies for rare ...

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing an integrated pipeline of genetic therapies for rare diseases, today announced an update ...

Rocket Pharmaceuticals acknowledged the death of a patient in a pivotal trial assessing its Danon disease gene therapy candidate RP-A501, a study that the FDA has placed on clinical hold.

In the single-arm Phase II trial, Rocket intends to treat 12 Danon disease patients with RP-A501. The gene therapy uses a recombinant adeno-associated serotype 9 capsid to deliver a full-length, ...